This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Resources - Whitepapers

PERFECT POTENT API PROCESSING: Handling Hazardous Drug Actives Effectively

The journey from discovery laboratory to pharmacy shelf is long and arduous, particularly for highly potent APIs, which must be handled in compliance with complex regulatory requirements at each stage of the journey.

Pharmaceutical companies looking for a Contract Development and Manufacturing Organization (CDMO) to help them navigate should look for one with a combination of true expertise, capabilities and a robust assessment process giving all molecules a “potent passport” according to David O’Connell, Director of Pharmaceutical Development at PCI Pharma Services.

PPAP: Handling Hazardous Drug Activities Effectively

December 20, 2016


PCI Welcomes UK Government to US Center of Excellence and Headquarters

PCI Pharma Services welcomed an official visit by the UK Government to our US Headquarters in Philadelphia, Pennsylvania this week.... View Article

PCI Welcomes Laura Zurlinden to West Coast Sales Team

PCI Pharma Services is pleased to announce Laura Zurlinden has accepted the role of Director of Business Development – West... View Article

x